The molecular genetics of migraine: Toward the identification of responsible genes

Current Genomics

Volumn 7, Issue 1, 2006, Pages 1-10

  Gianfrancesco, Fernando ^a   Esposito, Teresa ^a  

^a CNR   (Italy)

Author keywords

Familial hemiplegic migraine; Migraine with aura; Migraine without aura

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; CLUSTER ANALYSIS; DIAGNOSTIC PROCEDURE; FAMILIAL HEMIPLEGIC MIGRAINE; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENE SEGREGATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MEDICAL RESEARCH; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOLECULAR GENETICS; MULTIGENE FAMILY; PATIENT CARE; POPULATION RESEARCH; PROGNOSIS; REVIEW; WESTERN HEMISPHERE;

EID: 33746880346     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920206776389757     Document Type: Review

References (103)

1. Stewart, W.F., Lipton, R.B., Celentano, D.D., Reed, M.L. Prevalence of migraine headache in the United States. JAMA 1992, 267: 64-69.
2. Lopez, A.D., Murray, C.C. The global burden of disease, 1990-2020. Nat. Med. 1998, 4: 1241-3.
3. Menken, M., Munsat, T.L., Toole, J.F. The global burden of disease study: implications for neurology. The ambulatory workload of office-based neurologists: implications of the National Ambulatory Medical Care Survey. Arch. Neurol. 2000, 57: 418-20.
4. Ducros, A., Tournier-Lasserve, E., Bousser, M.G. The genetics of migraine. Lancet Neurol. 2002, 1: 285-93.
5. Honkasalo, M.L., Kaprio, J., Winter, T., Heikkila, K., Sillanpaa, M., Koskenvuo, M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache 1995, 35: 70-78.
6. Larsson, B., Bille, B., Pedersen, N.L. Genetic influence in headaches: a Swedish twin study. Headache 1995, 35: 513-519.
7. Gervil, M., Ulrich, V., Kaprio,. J., Olesen, J., Russell, M.B. The relative role of genetic and environmental factors in migraine without aura. Neurology 1999, 53: 995-999.
8. Gervil, M., Ulrich, V., Kyvik, K.O., Olesen, J., Russell, M.B. Migraine without aura: a population-based twin study. Ann. Neurol. 1999, 46: 606-611.
9. Ulrich, V., Gervil, M., Kirsten, F., Olesen, J., Russell, M.B. The prevalence and characteristics of migraine in twins from the general population. Headache 1999, 39: 173-180.
10. Mochi, M., Sangiorgi, S., Cortelli, P., Carelli, V., Scapoli, C., Crisci, M., Monari, L., Pierangeli, G., Montagna, P. Testing models for genetic determination in migraine. Cephalalgia 1993, 13: 389-394.
11. Russell, M.B., Olesen, J. Increased familial risk and evidence of genetic factor in migraine. Brit. Med. J. 1995, 311: 541-544
12. Rasmussen, B.K. Epidemiology of headache. Cephalalgia 2001, 21: 774-7.
13. Dahlöf, C., Linde, M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 2001, 21: 664-71.
14. Stewart, W.F., Staffa, J., Lipton, R.B., Ottman, R. Familial risk of migraine:a population-based study. Ann. Neurol. 1997, 41: 166-72.
15. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004, 24, Supplement 1: 1-52.
16. Russell, M.B., Rasmussen, B.K., Thorvaldsen, P., Olesen, J. Prevalence and sex-ratio of the subtypes of migraine. Int. J. Epidemiol. 1995, 24: 612-618.
17. Iadecola, C. From CSD to headache: a long and winding road Nat. Med. 2002, 8: 110-112.
18. Lauritzen, M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994, 117: 199-210.
19. Lashley, K. Patterns of cerebral integregation indicated by the scotomas of migraine. Arch. Neurol. Psychiatry 1941, 46: 331-339.
20. Pietrobon, D., Striessnic. J. Neurobiology of migraine. Nat. Rev. Neurosci. 2003, 4: 386-98.
21. Silberstein, S.D. Migraine. Lancet 2004, 363: 381-91.
22. Olesen, J., Friberg, L., Skyhoj-Olsen, T. Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann. Neurol. 1990, 28: 791-98.
23. Olesen, J., Larsen, B., Lauritzen, M. Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann. Neurol. 1981, 9: 344-52.
24. Olesen, J. Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications. Cerebrovasc Brain Metab. Rev. 1991, 3: 1-28.
25. Sanchez del Rio, M., Bakker, D., Wu, O., Agosti, R., Mitsikostas, D.D., Ostergaard, L., Wells, W.A., Rosen, B.R., Sorensen, G., Moskowitz, M.A., Cutrer, F.M. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 1999, 19: 701-7.
26. Cutrer, F.M., Sorensen, A.G., Weisskoff, R.M., Ostergaard, L., Sanchez del Rio, M., Lee, E.J., Rosen, B.R., Moskowitz, M.A. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann. Neurol. 1998, 43: 25-31.
27. Cao, Y., Welch, K.M., Aurora, S., Vikingstad, E.M. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch. Neurol. 1999, 56: 548-54.
28. Andersen, A.R., Friberg, L., Skyloj-Olsen, T., Olesen, J. Delayed hyperemia following hypoperfusion in classic migraine: single photon emission tomographic demonstration. Arch. Neurol. 1988, 45: 154-59.
29. Seto, H., Shimizu, M., Futatsuya, R., Kageyama, M., Wu, Y., Kamei, T., Shibata, R., Kakishita, M. Basilar artery migraine. Reversible ischemia demonstrated by Tc-99m HMPAO brain SPECT. Clin. Nucl. Med. 1994, 19: 215-8.
30. Woods, R.P., Iacoboni, M., Mazziotta, J.C. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headaches. N Engl. J. Med. 1994, 331: 1689-92.
31. Somjen, G. G. Mechanisms of spreading depression and hypoxic spreading depression- like depolarization. Physiol. Rev. 2001, 81: 1065-1096.
32. Strassman, A. M., Raymond, S. A. & Burstein, R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996, 384: 560-564.
33. Bolay, H., Reuter, U., Dunn, A.K., Huang, Z., Boas, D.A., Moskowitz, M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med. 2002, 8: 136-142.
34. Waeber, C., Moskowitz, M.A. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 2003, 61(Suppl.4): S9-20
35. Samsam, M., Covenas, R., Csillik, B., Ahangari, R., Yajeya, J., Riquelme, R., Narvaez, J.A., Tramu, G. Depletion of substance P, neurokinin A and calcitonin gene-related peptide from the contralateral and ipsilateral caudal trigeminal nucleus following unilateral electrical stimulation of the trigeminal ganglion; a possible neurophysiological and neuroanatomical link to generalized head pain. J. Chem. Neuroanat. 2001, 21: 161-9.
36. Ducros, A., Denier, C., Joutel, A., Cecillon, M., Lescoat, C., Vahedi, K., Darcel, F., Vicaut, E., Bousser, M.G., Tournier-Lasserve, E. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 2001, 345: 17-24.
37. Ophof, R.A., Terwindt, G.M., Vergouwe, M.N., van Eijk, R., Oefner, P.J., Hoffman, S.M., Lamerdin, J.E., Mohrenweiser, H.W., Bulman, D.E., Ferrari, M., Haan, J., Lindhout, D., van Ommen, G.J., Hofker. M.H., Ferrari, M.D., Frants, R.R. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87: 543-52.
38. Kors, E.E., Terwindt, G.M., Vermeulen, F.L., Fitzsimons, R.B., Jardine, P.E., Heywood, P., Love, S., van den Maagdenberg, A.M., Haan, J., Frants, R.R., Ferrari, M.D. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol. 2001, 49: 753-60.
39. Thomsen, L.L., Olesen, J., Russell, M.B. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur. J. Neurol. 2003, 10: 421-427.
40. Wessman, M., Kaunisto, M.A., Kallela, M., Palotie, A. The molecular genetics of migraine. Ann. Med. 2004, 36: 462-473.
41. Wappl, E., Koschak, A., Poteser, M., Sinnegger, M.J., Walter, D., Eberhart, A., Groschner, K., Glossmann, H., Kraus, R.L., Grabner, M., Striessnig, J. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J. Biol. Chem. 2002, 277: 6960-6.
42. Ayata, C., Shimizu-Sasamata, M., Lo, E.H., Noebels, J.L., Moskowitz, M.A. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience 2000, 95: 639-45.
43. De Fusco, M., Marconi, R., Silvestri, L., Atorino, L., Rampoldi, L., Morgante, L., Ballabio, A., Aridon, P., Casari, G. Haploinsufficiency of ATP1A2 encoding the Na+/K+pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 2003, 33: 192-196.
44. Estevez, M., Gardner, K.L. Update on the genetics of migraine. Hum. Genet. 2004, 114: 225-35.
45. Ducros, A., Joutel, A., Vahedi, K., Cecillon, M., Ferreira, A., Bernard, E., Verier, A., Echenne, B., Lopez de Munain, A., Bousser, M.G., Tournier-Lasserve, E. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann. Neurol. 1997, 42: 885-90.
46. Riant, F., De Fusco, M., Aridon, P., Ducros, A., Ploton, C., Marchelli, F., Maciazek, J., Bousser, M.G., Casari, G., Tournier-Lasserve, E. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum. Mutat. 2005, 3: 281.
47. Dichgans, M., Freilinger, T., Eckstein, G., Babini, E., Lorenz-Depiereux, B., Biskup, S., Ferrari, M.D., Herzog, J., van den Maagdenberg, A.M., Pusch, M., Strom, T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366: 371-377.
48. Jen, J.C., Kim, G.W., Dudding, K.A., Balch, R.W. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine Arch. Neurol. 2004, 61: 926-8.
49. Dichgans, M., Mayer, M., Uttner, I., Bruning, R., Muller-Hocker, J., Rungger, G., Ebke, M., Klockgether, T. and Gasser, T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann. Neurol. 1998, 44: 731-739.
50. Montagna, P., Gallassi, R., Medori, R., Govoni, E., Zeviani, M., Di Mauro, S., Lugaresi, E. and Andermann, F. MELAS syndrome, characteristic migrainous and epileptic features and maternal transmission. Neurology 1988, 38: 751-755.
51. Klopstock, T., May, A., Seibel, P., Papagiannuli, E., Diener, H.C. and Reichmann, H. Mitochondrial DNA in migraine with aura. Neurology 1996, 46: 1735-1743.
52. Haan, J., Terwindt, G.M., Maassen, J.A., Hart, L.M., Frants, R.R. and Ferrari, M.D. SeArch. for mitochondrial DNA mutations in migraine subgroups. Cephalalgia 1999, 19: 20-22.
53. Lea, R.A., Shepherd, A.G., Curtain, R.P., Nyholt, D.R., Quinlan, S., Brimage, P.J., Griffiths, L.R. A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics 2002, 4: 17-22.
54. Nyholt, D.R., Dawkins, J.L., Brimage, P.J., Goadsby, P.J., Nicholson, G.A., Griffiths, L.R. Evidence for an X-linked genetic component in familial typical migraine. Hum. Mol. Genet. 1998, 7: 459-463.
55. Nyholt, D.R., Curtain, R.P., Griffiths, L.R. Familial typical migraine:significant linkage and localization of a gene to Xq24-28. Hum. Genet. 2000, 107: 18-23.
56. Wessman, M., Kallela, M., Kaunisto, M.A., Marttila, P., Sobel, E., Hartiala, J., Oswell, G., Leal, S.M., Papp, J.C., Hamalainen, E., Broas, P., Joslyn, G., Hovatta, I., Hiekkalinna, T., Kaprio, J., Ott, J., Cantor, R.M., Zwart, J.A., Ilmavirta, M., Havanka, H., Farkkila, M., Peltonen, L., Palotie, A. A susceptibility locus for migraine with aura, on chromosome 4q24. Am. J. Hum. Genet. 2002, 70: 652-62.
57. Bjornsson, A., Gudmundsson, G., Gudfinnason, E., Hrafnsdottir, M., Benedikz, J., Skuladottir, S., Kristjansson, K., Frigge, M.L., Kong, A., Stefansson, K., Gulcher, J.R. Localization of a gene for migraine without aura to chromosome 4q21. Am. J. Hum. Genet. 2003, 73: 986-93.
58. Carlsson, A., Forsgren, L., Nylander, P.O., Hellman, U., Forsman-Semb, K., Holmgren, G., Holmberg, D., Holmberg, M. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 2002, 59: 1804-7.
59. Cader, Z.M., Noble-Topham, S., Dyment, D.A., Cherny, S.S., Brown, J.D., Rice, G.P., Ebers, G.C. Significant linkage to migraine with aura on chromosome 11q24. Hum. Mol. Genet. 2003, 12: 2511-7.
60. Soragna, D., Vettori, A., Carraro, G., Marchioni, E., Vazza, G., Bellini, S., Tupler, R., Savoldi, F., Mostacciuolo, M.L. A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum. Genet. 2003, 72: 161-7.
61. Russo, L., Mariotti, P., Sangiorgi, E., Giordano, T., Ricci, I., Lupi, F., Chiera, R., Guzzetta, F., Neri, G., Gurrieri, F. A New Susceptibility Locus for Migraine with Aura in the 15q11-q13 Genomic Region Containing Three GABA-A Receptor Genes. Am J. Hum. Genet. 2005, 76: 327-33.
62. Jones, K.W., Ehm, M.G., Pericak-Vance, M.A., Haines, J.L., Boyd, P.R., Peroutka, S.J. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics 2001, 78: 150-54.
63. McCarthy, L.C., Hosford, D.A., Riley, J.H., Bird, M.I., White, N.J., Hewett, D.R., Peroutka, S.J., Griffiths, L.R, Boyd, P.R., Lea, R.A., Bhatti, S.M., Hosking, L.K., Hood, C.M., Jones, K.W., Handley, A.R., Rallan, R., Lewis, K.F., Yeo, A.J., Williams, P.M., Priest, R.C., Khan, P., Donnelly, C., Lumsden, S.M., O'Sullivan, J., See, C.G., Smart, D.H., Shaw-Hawkins, S., Patel, J., Langrish, T.C., Feniuk, W., Knowles, R.G., Thomas, M., Libri, V., Montgomery, D.S., Manasco, P.K., Xu, C.F., Dykes, C., Humphrey, P.P., Roses, A.D., Purvis, I.J. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001, 78: 135-149.
64. Nightingale, A.L., Farmer, R.D. Ischemic Stroke in Young Women. A Nested Case-Control Study Using the UK General Practice ReseArch. Database. Stroke 2004, 13: 13
65. Tzourio, C., Tehindrazanarivelo, A., Iglesias, S., Alperovitch, A., Chedru, F., d'Anglejan-Chatillon, J., Bousser, M.G. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995, 310: 830-3.
66. Carolei, A., Marini, C., De Matteis, G. History of migraine and risk of cerebral ischaemia in young adults. Lancet 1996, 347: 1503-6.
67. Chang C.L., Donaghy, M., Poulter, N. Migraine and stroke in young women:case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999, 318: 13-8
68. Buring, J.E., Hebert, P., Romero, J., Kittross, A., Cook, N., Manson, J., Peto, R., Hennekens, C. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch. Neurol. 1995, 52: 129-34.
69. Hoekstra-van Dalen, R.A., Cillessen, J.P., Kappelle, L.J., van Gijn, J. Cerebral infarcts associated with migraine: clinical features, risk factors and follow-up. J. Neurol. 1996, 243: 511-5.
70. Merikangas, K.R., Fenton, B.T., Cheng, S.H., Stolar, M.J., Risch, N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch. Neurol. 1997, 54: 362-8.
71. Milhaud, D., Bogousslavsky, J., van Melle, G., Liot, P. Ischemic stroke and active migraine. Neurology 2001, 57: 1805-11.
72. Bousser, M.G., Conard, J., Kittner, S., de Lignieres, B., MacGregor, E.A., Massiou, H., Silberstein, S.D., Tzourio, C. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000, 20: 155-6.
73. Bousser, M.G., Kittner, S.J. Oral contraceptives and stroke. Cephalalgia 2000, 20: 183-9.
74. Tzourio, C., Kittner, S.J., Bousser, M.G., Alperovitch, A. Migraine and stroke in young women. Cephalalgia 2000, 20: 190-9.
75. Etminan, M., Takkouche, B., Isorna, F.C., Samii, A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005, 330: 63.
76. Pantoni, L., Garcia, J.H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995, 26: 1293-301.
77. Goldberg, M.P., Ransom, B.R. New light on white matter. Stroke 2003, 34: 330-2
78. Soges, L.J., Cacayorin, E.D., Petro, G.R., Ramachandran, T.S. Migraine: evaluation by MR. AJNR Am. J. Neuroradiol. 1988, 9: 425-9.
79. Igarashi, H., Sakai, F., Kan, S., Okada, J., Tazaki, Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991, 11: 69-74.
80. Osborn, R.E., Alder, D.C., Mitchell, C.S. MR imaging of the brain in patients with migraine headaches. AJNR Am. J. Neuroradiol. 1991, 12: 521-4.
81. Ziegler, D.K., Batnitzky, S., Barter, R., McMillan, J.H. Magnetic resonance image abnormality in migraine with aura. Cephalalgia 1991, 11: 147-50.
82. Fazekas, F., Koch, M., Schmidt, R., Offenbacher, H., Payer, F., Freidl, W., Lechner, H. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache 1992, 32: 287-91.
83. Robbins, L., Friedman, H. MRI in migraineurs. Headache 1992, 32: 507-8.
84. Pavese, N., Canapicchi, R., Nuti, A., Bibbiani, F., Lucetti, C., Collavoli, P., Bonuccelli, U. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia 1994, 14: 342-5.
85. de Benedittis, G., Lorenzetti, A., Sina, C., Bernasconi, V. Magnetic resonance imaging in migraine and tension-type headache. Headache 1995, 35: 264-8.
86. Cooney, B.S., Grossman, R.I., Farber, R.E., Goin, J.E., Galetta, S.L. Frequency of magnetic resonance imaging abnormalities in patients with migraine. Headache 1996, 36: 616-21.
87. Swartz, R.H., Kern, R.Z. Migraine is associated with magnetic resonance imaging white matter abnormalities. Arch. Neurol. 2004, 61: 1366-1368.
88. Kruit, M.C., van Buchem, M.A., Hofman, P.A., Bakkers, J.T., Terwindt, G.M., Ferrari, M.D., Launer, L.J. Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291: 427-34.
89. Wilmshurst, P., Nightingale, S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin. Sci. 2001, 100: 215-220.
90. Del Sette, M., Angeli, S., Leandri, M., Ferriero, G., Bruzzone, G.L., Finocchi, C., Gandolfo, C. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc. Dis. 1998, 8: 327-30.
91. Anzola, G.P., Magoni, M., Guindani, M., Rozzini, L., Dalla Volta, G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52: 1622-5.
92. Venketasubramanian, N., Sacco, R.L., Di Tullio, M., Sherman, D., Homma, S., Mohr, J.P. Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993, 43: 1533-5.
93. Wilmshurst, P.T., Nightingale, S., Walsh, K.P., Morrison, WmL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356: 1648-51.
94. Azarbal, B., Tobis, J., Suh, W., Chan, V., Dao, C., Gaster, R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J. Am. Coll. Cardiol. 2005, 45: 489-92.
95. Reisman, M., Christofferson, R.D., Jesurum, J., Olsen, J.V., Spencer, M.P., Krabill, K.A., Diehl, L., Aurora, S., Gray, W.A. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Cardiol. 2005, 45: 493-5.
96. Tsimikas, S. Transcatheter closure of patent foramen ovale for migraine prophylaxis: hope or hype? J. Am. Coll. Cardiol. 2005, 45: 496-8.
97. Schwerzmann, M., Wiher, S., Nedeltchev, K., Mattle, H.P., Wahl, A., Seiler, C., Meier, B., Windecker, S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004, 62: 1399-401.
98. Morandi, E., Anzola, G.P., Angeli, S., Melzi, G., Onorato, E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J. Interv. Cardiol. 2003, 16: 39-42.
99. Dahlöf, C.G.H. Is migraine a progressive brain disease with increasingly impaired cerebral functioning? Headache Care 2004, 1: 247-260.
100. Lipton, R.B., Stewart, W.F. Migraine headaches: epidemiology and comorbidity. Clin. Neurosci. 1998, 5: 2-9.
101. Breslau, N., Lipton, R.B., Stewart, W.F., Schultz, L.R., Welch, K.M. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003, 60: 1308-1312.
102. Low, N.C., Merikangas, K.R. The comorbidity of migraine. CNS Spectr. 2003, 8: 433-4.
103. O'Keeffe, S.T., Tsapatsaris, N.P., Beetham, W.P. Association between Raynaud 's phenomenon and migraine in a random population of hospital employees. J. Rheumatol. 1993, 20: 1187-1188.